Audience Q&A - State-of-the-art-lipid treatment in coronary patients in 2017.
Topic:
Lipids (Epidemiology and Prevention)
Speaker:
Doctor M. Bonaca (Aurora, US)
Professor E. Braunwald (Boston, US)
Professor F. Mach (Geneva, CH)
Sponsored by MSD
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Doctor Marc Bonaca
University of Colorado Anschutz Medical Campus, Aurora (United States of America)
29
presentations
1
follower
Professor Eugene Braunwald
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
37
presentations
9
followers
Professor Francois Mach
Geneva University Hospitals, Geneva (Switzerland)
21
presentations
2
followers
4 more presentations in this session
A clinician's perspective on recent guidelines in clinical practice.
Speaker: Doctor M. Bonaca (Aurora, US)
State-of-the-art lipid-lowering combination therapies.
Speaker: Professor F. Mach (Geneva, CH)
Emerging science: recent evidence and science on the horizon.
Speaker: Professor E. Braunwald (Boston, US)
Access the full session
State-of-the-art lipid treatment in coronary patients in 2017
Speakers:
Doctor M. Bonaca, Professor E. Braunwald, Professor F. Mach, Doctor M. Bonaca, Professor F. Mach...
About the event
ESC 365 is supported by
